Physician profile
Ramonica Flagler
NPI 1225670037
$4,366.67
in general payments reported to CMS, 2019-2025
7 companies · $1,902 in 2025
The $1,902 reported for 2025 was more than what 93% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $811 · 2024: $1,653 · 2025: $1,902.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,302 · Education: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,301.67 |
| Education | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $1,598.08 | 2023-2025 | Dovato, Apretude, Rukobia |
| Gilead Sciences, INC. | $1,425.57 | 2023-2025 | Biktarvy |
| Theratechnologies INC. | $804.79 | 2023-2025 | Egrifta, Trogarzo, Egrifta Sv |
| Merck Sharp & Dohme LLC | $442.15 | 2023-2025 | Pifeltro, Delstrigo, Isentress |
| Janssen Biotech, INC. | $35.28 | 2023 | Symtuza |
| Emd Serono, INC. | $34.37 | 2023-2025 | Serostim |
| Indivior INC. | $26.43 | 2023 | Sublocade |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramonica Flagler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.